Virtu Financial’s Genomic Health, Inc. GHDX Stock Holding History

Virtu Financial’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,953	Closed	-$200K	–	2055
2019 Q3	$200K	Buy	+2,953	New	+$203K	0.02%	975
2019 Q2	–	Sell	-4,701	Closed	-$329K	–	2069
2019 Q1	$329K	Buy	+4,701	New	+$349K	0.02%	741
2018 Q3	–	Sell	-11,833	Closed	-$596K	–	2495
2018 Q2	$596K	Buy	+11,833	New	+$470K	0.04%	693
2018 Q1	–	Sell	-7,622	Closed	-$261K	–	2960
2017 Q4	$261K	Buy	+7,622	New	+$243K	0.01%	1390

Virtu Financial's GHDX Position: Q4 2019 in Review

Virtu Financial sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 2,953 shares — an estimated $200K sold.

Virtu Financial first reported a position in GHDX in Q4 2017 and held it in 4 quarters. The position peaked at $596K in Q2 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Virtu Financial reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Virtu Financial sold 2,953 Genomic Health, Inc. shares in Q4 2019, an estimated $200K.
Virtu Financial first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 4 quarters.
Virtu Financial's Genomic Health, Inc. position peaked at $596K in Q2 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.